Brain Connectome Graphs based Machine Learning for Diagnosis of Alzheimer’s Disease

Ke Chen, Ying Weng, Tom Dening, Akram A. Hosseini, Guokun ZuoAlzheimer 2024 · DOI

TL;DR

This paper introduces a novel framework for diagnosing Alzheimer's Disease (AD) by integrating structural and functional brain connectome graphs with machine learning. By treating brain connectivity as a graph, they leverage Graph Neural Networks (GNNs) to achieve high diagnostic accuracy, paving the way for earlier and more personalized interventions.

What Problem Does This Paper Address?

Alzheimer's Disease (AD) is a devastating neurodegenerative disorder characterized by progressive cognitive decline and memory loss. Early and accurate diagnosis is critical for patient care, enabling advance planning and the potential for timely interventions. However, current diagnostic methods can be invasive, expensive, or lack the sensitivity to detect the disease in its early stages, particularly Mild Cognitive Impairment (MCI). This paper addresses the challenge of improving AD diagnosis by exploring the complex network alterations in the brain, known as connectomes, and applying advanced machine learning techniques to these network representations.

Methods

The authors propose a three-stage framework for AD diagnosis:

  1. Image Pre-processing: Standard neuroimaging data (dMRI and fMRI) are pre-processed using established pipelines like PANDA and fMRIPrep. This step ensures the data is clean and ready for subsequent analysis.
  2. Brain Connectome Graph Construction: This is a key innovation. Instead of analyzing individual brain regions in isolation, the researchers construct brain connectome graphs. These graphs represent the brain as a network where nodes are brain regions and edges represent the strength of structural (from dMRI) or functional (from fMRI) connections between them. This allows for the analysis of how different brain regions communicate and interact.
  3. Machine Learning-based AD Diagnosis: The structural and functional connectome graphs are then used as joint inputs for Graph Neural Network (GNN)-based models. GNNs are particularly well-suited for analyzing graph-structured data, allowing them to learn complex patterns within the brain's connectivity network. The GNN models are trained to predict AD, MCI, and cognitively normal (CN) states. Additionally, explainable AI techniques are employed to visualize the decision-making process of the models, offering insights into which connectivity patterns are most indicative of AD.

Datasets

The study utilizes data from the Alzheimer's Disease Neuroimaging Initiative (ADNI). This is a well-established, publicly available dataset that has been instrumental in AD research. The authors use both diffusion MRI (dMRI) and functional MRI (fMRI) data from ADNI. No new benchmarks or datasets were introduced in this paper.

Key Insights and Ideas

  • Brain connectivity as a diagnostic biomarker: The core idea is that AD isn't just about damage to individual brain regions, but also about the disruption of communication networks between them. Representing these networks as graphs allows for a more holistic analysis.
  • Synergy of structural and functional connectomes: By combining both structural (physical pathways) and functional (correlated activity) connectome information, the models can capture a more comprehensive picture of brain network alterations in AD.
  • Power of Graph Neural Networks: GNNs are shown to be highly effective in learning from complex graph data, making them a powerful tool for analyzing brain connectomes for diagnostic purposes.
  • Explainable AI for trust and understanding: The use of explainable AI is crucial. It not only helps validate the model's predictions but also provides neuroscientists with insights into the specific connectivity changes that are most predictive of AD, potentially leading to new hypotheses about disease mechanisms.

Key Results

The experiments conducted on the ADNI dataset demonstrated promising results with high performance in identifying patients with AD, MCI, and cognitively normal (CN) individuals. While specific accuracy percentages are not detailed in the abstract, the paper emphasizes the "high performance" achieved by the GNN-based models. The explainable AI algorithms provided visualizations of the models' decision strategies, offering insights into the diagnostic process.

Limitations and Future Work

The paper highlights that this research contributes to the burgeoning field of neuroinformatics by offering a "novel and effective approach." The integration of machine learning with brain connectome graphs has the potential for early and accurate identification of individuals at risk of AD. This could pave the way for timely interventions and personalized treatment strategies. The study also aims to shed light on the intricate connectome-level changes associated with AD, fostering a deeper understanding of the disease's pathophysiology. Ultimately, this research is presented as a significant step towards leveraging advanced computational techniques to enhance AD diagnosis and management.

Limitations are not explicitly detailed in the provided abstract, but future work would likely involve validating these findings on larger and more diverse datasets, exploring different GNN architectures, and further refining the explainable AI components to provide deeper biological insights.

Summary updated

Abstract

The findings of our research contribute to the burgeoning field of neuroinformatics by offering a novel and effective approach to AD diagnosis. The integration of machine learning with brain connectome graphs has potential to provide early and accurate identification of individuals at risk of AD, and pave the way for timely interventions and personalized treatment strategies. Moreover, this study sheds light on the intricate connectome-level changes associated with AD and fosters a deeper understanding of the disease's pathophysiology. Ultimately, this research has established a significant step towards leveraging advanced computational techniques to enhance our ability to diagnose and manage AD.
BibTeX
@inproceedings{chen2024brain,
  author = {Ke Chen and Ying Weng and Tom Dening and Akram A. Hosseini and Guokun Zuo},
  title = {{Brain Connectome Graphs based Machine Learning for Diagnosis of Alzheimer’s Disease}},
  booktitle = {Alzheimer},
  year = {2024},
  doi = {10.1002/alz.090237},
}
Figure